| Joseph P Catlett, MD | |
|
110 Irving St Nw, Suite 2a38, Washington, DC 20010-2976 | |
| (202) 877-2848 | |
| Not Available |
| Full Name | Joseph P Catlett |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 110 Irving St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295788263 | NPI | - | NPPES |
| 025637600 | Medicaid | DC | |
| 6038557 | Medicaid | VA | |
| 135321700 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD20542 (District Of Columbia) | Primary |
| Entity Name | Whc Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700154226 PECOS PAC ID: 6103093513 Enrollment ID: O20120125000252 |
News Archive
Agreement by governments, by the end of 2012, on a set of ambitious global targets to curb the growing scourge of non-communicable diseases (NCDs), which includes cardiovascular disease (CVD; heart disease and stroke), is critical to avoiding the millions of premature deaths worldwide. This, according to a new paper published by the Global Cardiovascular Disease Taskforce a group of eminent experts who represent five leading heart-health organizations.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
CBH is the first hospital in Central Kentucky to perform the transcatheter aortic valve replacement (TAVR) procedure. Four patients with diseased aortic heart valves who were deemed too sick to withstand conventional open-heart surgery to replace their valves have undergone this new heart valve replacement procedure at Central Baptist Hospital.
New research has highlighted the potential gender gap in stress, with women reporting higher stress from life events such as death of a loved one, illness, losing their smartphone and Brexit.
Smith & Nephew's (NYSE: SNN) (LSE: SN) Advanced Wound Management division, announce the European launch of ACTICOAT™ Flex 3 and ACTICOAT™ Flex 7, to expand the ACTICOAT portfolio. The Flex range provides enhanced conformability to better address patient comfort and in utilizing the Silcryst™ nanocrystalline silver technology, ACTICOAT Flex products have been designed to support physicians dealing with soft tissue injuries at high risk of infection.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph P Catlett, MD 110 Irving St Nw, Suite 2a38, Washington, DC 20010-2976 Ph: (202) 877-2848 | Joseph P Catlett, MD 110 Irving St Nw, Suite 2a38, Washington, DC 20010-2976 Ph: (202) 877-2848 |
News Archive
Agreement by governments, by the end of 2012, on a set of ambitious global targets to curb the growing scourge of non-communicable diseases (NCDs), which includes cardiovascular disease (CVD; heart disease and stroke), is critical to avoiding the millions of premature deaths worldwide. This, according to a new paper published by the Global Cardiovascular Disease Taskforce a group of eminent experts who represent five leading heart-health organizations.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
CBH is the first hospital in Central Kentucky to perform the transcatheter aortic valve replacement (TAVR) procedure. Four patients with diseased aortic heart valves who were deemed too sick to withstand conventional open-heart surgery to replace their valves have undergone this new heart valve replacement procedure at Central Baptist Hospital.
New research has highlighted the potential gender gap in stress, with women reporting higher stress from life events such as death of a loved one, illness, losing their smartphone and Brexit.
Smith & Nephew's (NYSE: SNN) (LSE: SN) Advanced Wound Management division, announce the European launch of ACTICOAT™ Flex 3 and ACTICOAT™ Flex 7, to expand the ACTICOAT portfolio. The Flex range provides enhanced conformability to better address patient comfort and in utilizing the Silcryst™ nanocrystalline silver technology, ACTICOAT Flex products have been designed to support physicians dealing with soft tissue injuries at high risk of infection.
› Verified 9 days ago
Dr. Adefolaju Oketokun, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |